Key result
Dobutamine echo and baseline EDV predict post-revascularization LV functional recovery with ~84% accuracy.
Why the study?
The ability of thallium imaging and low-dose dobutamine echocardiography to predict reversibility of LV dysfunction after coronary revascularization in patients with depressed LV function was evaluated.
Does preoperative assessment with dobutamine echocardiography and thallium SPECT predict the recovery of left ventricular function in patients with coronary disease and ejection fraction <= 35% undergoing revascularization?
Cohort (n=40)
Does preoperative assessment with dobutamine echocardiography and thallium SPECT predict the recovery of left ventricular function in patients with coronary disease and ejection fraction <= 35% undergoing revascularization?
In patients with coronary disease and severe LV dysfunction, preoperative inotropic reserve on dobutamine echocardiography and baseline end-diastolic volume independently predict the recovery of LV function after revascularization.
Answers are grounded in this paper and cite their sources.
May support dobutamine echo for predicting LV recovery post-revascularization in severe dysfunction; leaves open prospective validation before practice change.
Background Both thallium imaging and low-dose dobutamine echocardiography have been proposed to predict the reversibility of left ventricular (LV) dysfunction in patients with coronary disease. The present study was designed to evaluate whether the use of these techniques during the preoperative assessment of coronary patients with depressed LV function can improve our ability to identify those likely to have improved LV function after surgery. Methods and Results Forty consecutive patients (age, 60±10 years) with coronary disease and an ejection fraction ≤35% underwent dobutamine echocardiography (10 μg/kg per minute) and exercise-redistribution-reinjection thallium single photon emission computed tomography (SPECT) before coronary revascularization by bypass surgery (n=33) or angioplasty (n=7). Recovery of LV function was evaluated by echocardiography 5.3±2.4 months after revascularization. According to the changes in end-systolic volume and ejection fraction after revascularization, the patients were categorized into groups with (n=19) and without (n=21) postoperative functional improvement, defined as a >5% increase in ejection fraction and >10 mL decrease in end-systolic volume. Before revascularization, patients with improved postoperative function had smaller end-diastolic volume and less wall motion abnormalities than those with persistent dysfunction. They also showed greater improvement of wall motion score with dobutamine (6.1±2.4 versus 1.8±4.2 grades, P <.001) and smaller thallium defect score after exercise (38±12 versus 47±14 grades, P =.04). Discriminant analysis selected the improvement in wall motion score with dobutamine and baseline end-diastolic volume as independent predictors of postoperative recovery. Consideration of both parameters allowed prediction of functional outcome in 84% of the patients with and 81% of those without postoperative improvement. Conclusions Among the parameters commonly available before surgery in coronary patients with depressed LV function, the maintenance of significant inotropic reserve, the severity of LV remodeling, and the magnitude of the perfusion defect after exercise can predict the reversal of LV dysfunction after revascularization.
No takes yet. Share an insight, caveat, or question.
Vanoverschelde et al. (1995) conducted a cohort in Coronary disease with depressed left ventricular function (n=40). Dobutamine echocardiography and thallium SPECT was evaluated on Postoperative functional improvement (>5% increase in ejection fraction and >10 mL decrease in end-systolic volume) (p=<.001).
Synapse has enriched 10 related papers. Consider them for comparative context: